Similar articles for PMID: 26380887

Year	Number of Results
2004	1
2009	1
2010	4
2011	5
2012	8
2013	11
2014	25
2015	33
2016	20
2017	16
2018	10
2019	6
2020	4
2021	7
2022	3
2023	1
2024	0

1

New guideline on treatment of idiopathic pulmonary fibrosis.

Spagnolo P, Bonella F, Maher TM. Spagnolo P, et al. Lancet Respir Med. 2015 Sep;3(9):e31-e32. doi: 10.1016/S2213-2600(15)00322-7. Lancet Respir Med. 2015. PMID: 26380887 No abstract available.

2

Novel treatments for idiopathic pulmonary fibrosis.

Spagnolo P. Spagnolo P. Am J Med. 2015 May;128(5):447-9. doi: 10.1016/j.amjmed.2015.01.003. Epub 2015 Jan 20. Am J Med. 2015. PMID: 25613299 No abstract available.

3

Hot off the breath: A big step forward for idiopathic pulmonary fibrosis.

Ryerson CJ, Collard HR. Ryerson CJ, et al. Thorax. 2014 Sep;69(9):791-2. doi: 10.1136/thoraxjnl-2014-205892. Epub 2014 Jul 4. Thorax. 2014. PMID: 24996636 No abstract available.

4

Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions.

Raghu G, Selman M. Raghu G, et al. Am J Respir Crit Care Med. 2015 Feb 1;191(3):252-4. doi: 10.1164/rccm.201411-2044ED. Am J Respir Crit Care Med. 2015. PMID: 25635489 No abstract available.

5

Therapeutic advances in idiopathic pulmonary fibrosis.

George G, Vaid U, Summer R. George G, et al. Clin Pharmacol Ther. 2016 Jan;99(1):30-2. doi: 10.1002/cpt.283. Epub 2015 Nov 18. Clin Pharmacol Ther. 2016. PMID: 26502087 No abstract available.

6

Two therapies now available for idiopathic pulmonary fibrosis.

Morrow T. Morrow T. Manag Care. 2014 Dec;23(12):47-8. Manag Care. 2014. PMID: 25939185 No abstract available.

7

[The Latest Information on Respiratory Disease Management. Topics: III. New Treatment of Idiopathic Pulmonary Fibrosis].

Kashiwada T, Azuma A. Kashiwada T, et al. Nihon Naika Gakkai Zasshi. 2016 Jun;105(6):970-6. Nihon Naika Gakkai Zasshi. 2016. PMID: 30168687 Japanese. No abstract available.

8

Clinical trial research in focus: why do so many clinical trials fail in IPF?

Spagnolo P, Maher TM. Spagnolo P, et al. Lancet Respir Med. 2017 May;5(5):372-374. doi: 10.1016/S2213-2600(17)30122-4. Epub 2017 Apr 12. Lancet Respir Med. 2017. PMID: 28412184 Free article. Review. No abstract available.

9

Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib.

Karimi-Shah BA, Chowdhury BA. Karimi-Shah BA, et al. N Engl J Med. 2015 Mar 26;372(13):1189-91. doi: 10.1056/NEJMp1500526. N Engl J Med. 2015. PMID: 25806913 No abstract available.

10

Update in Interstitial Lung Disease 2014.

Belloli EA, Martinez FJ, Flaherty KR. Belloli EA, et al. Am J Respir Crit Care Med. 2015 Sep 1;192(5):538-43. doi: 10.1164/rccm.201504-0768up. Am J Respir Crit Care Med. 2015. PMID: 26561676 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

143 results

Results by year